ArticleHSOA journal of alternative, complementary & integrative medicine2024
Cytoprotection against Cadmium by Nrf2-Activating Dietary Phytochemicals.
Article in HSOA journal of alternative, complementary & integrative medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Background: Environmental exposure to toxic heavy metals such as cadmium continues to cause significant human health impacts around the world. Objective: This aim of this study was to determine potential benefits of a Nrf2 activating phytochemical combination against cadmium-induced cytotoxicity. Methods: Human Hepatocellular Carcinoma (HepG2) cells were treated with the Nrf2-activating PB123 combination of dietary phytochemicals and the cultured HepG2 cells were challenged with cadmium (CdSO4). Cytotoxicity effects were evaluated by assays of cell viability (CCK8 assay) and cell injury (LDH release assay). Gene mRNA expression in PB123-treated cells was determined by RNA-seq. Results: PB123 upregulated metallothionein gene expression in the HepG2 cells, and pretreatment with PB123 protected HepG2 cells from Cd2+ toxicity measured both as cell viability (CCK8 assay) and cell injury (LDH release assay). Use of the Nrf2-inhibitor AEM1 suggested a Nrf2-dependence of the PB123-induced protection. Transcriptomic analyses of gene expression data from PB123-treated cells revealed both Nrf2-related and metallothionein-related pathways as key Reactome findings, and Detoxification as a primary Gene Ontology endpoint. Conclusion: In context with previous work by others, the present findings indicate that rosemary-based dietary supplement products like PB123 might promote beneficial responses against environmental cadmium exposure.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.